Brainsway Ltd Sponsored ADR Aktie News

BrainsWay reported strong Q1 results with profitability, positive cash flow, and strong growth. Market conditions have supposedly affected Neuronetics, but BrainsWay has not experienced similar problems. BrainsWay continues to expand its installed base and is exploring new indications for TMS treatment.

BrainsWay Ltd. (NASDAQ:BWAY ) Q1 2024 Earnings Conference Call May 8, 2024 8:30 AM ET Company Participants Troy Williams – Investor Relations, Life Science Advisors Hadar Levy – Chief Executive Officer Ido Marom – Chief Financial Officer Conference Call Participants Jeff Cohen – Ladenburg Steve Lichtman – Oppenheimer Ram Selvaraju – H.C.

Generated Significant 37% Year-over-Year Revenue Growth in Q1 2024 Recorded Positive Quarterly Net Income for Second Consecutive Quarter, and Positive Adjusted EBITDA and Cash Flow from Operations for Third Consecutive Quarter Conference Call to be Held Today at 8:30 AM ET BURLINGTON, Mass. and JERUSALEM, May 08, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd.

BURLINGTON, Mass. and JERUSALEM, April 24, 2024 (GLOBE NEWSWIRE) -- BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a global leader in advanced noninvasive neurostimulation treatments for mental health disorders, today announced that it will report its first quarter 2024 financial results as well as operational highlights before the open of the U.S. financial markets on Wed...

Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor Symptoms Clinical Data from Multiple Trials Showed Improvements in Both Motor and Non-Motor Symptoms

Katie's Way Provides Lifesaving Mental Health Treatment Nationally with a Focus on Servicemembers, Veterans, and their Families Katie's Way Provides Lifesaving Mental Health Treatment Nationally with a Focus on Servicemembers, Veterans, and their Families

Generally speaking, you want to minimize your exposure to cheap stocks under $10. Yes, smaller companies have the potential to rise dramatically higher than their larger counterparts.

BrainsWay Ltd. (NASDAQ:BWAY) Q4 2023 Earnings Conference Call March 6, 2024 8:30 AM ET